Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7–30.
Article
PubMed
Google Scholar
Srigley JR, Delahunt B, Eble JN, Egevad L, Epstein JI, Grignon D, et al. The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasia. Am J Surg Pathol. 2013;37:1469–89.
Article
PubMed
Google Scholar
Rydzanicz M, Wrzesiński T, Bluyssen HA, Wesoły J. Genomics and epigenomics of clear cell renal cell carcinoma: recent developments and potential applications. Cancer Lett. 2013;341:111–26.
Article
CAS
PubMed
Google Scholar
Martel CL, Lara PN. Renal cell carcinoma: current status and future directions. Crit Rev Oncol Hematol. 2003;45(2):177–90.
Article
PubMed
Google Scholar
McLaughlin J, Lipworth L, Tarone R, Blot W. Cancer Epidemiology and Prevention. Oxford Univ. Press; 2006. p. 1087–100.
Chow WH, Dong LM, Devesa SS. Epidemiology and risk factors for kidney cancer. Nat Rev Urol. 2010;7:245–57.
Article
PubMed
PubMed Central
Google Scholar
Gospodarowicz MK, Miller D, Groome PA, Greene FL, Logan PA, Sobin LH. The process for continuous improvement of the TNM classification. Cancer. 2004;100(1):1–5.
Article
PubMed
Google Scholar
Powles T, Staehler M, Ljungberg B, Bensalah K, Canfield SE, Dabestani S, et al. European Association of Urology guidelines for clear cell renal cancers that are resistant to vascular endothelial growth factor receptor-targeted therapy. Eur Urol. 2016;70(5):705–6.
Article
PubMed
Google Scholar
Jonasch E, Gao J, Rathmell WK. Renal cell carcinoma. BMJ. 2014;349:4797.
Article
Google Scholar
Ljungberg B, Bensalah K, Bex A, Canfield S, Dabestani S, Hofmann F, et al. Guidelines on renal cell carcinoma: 2014 update. Eur Assoc Urol. 2015;67:913–24.
Article
Google Scholar
Singer EA, Gupta GN, Srinivasan R. Update on targeted therapies for clear cell renal cell carcinoma. Curr Opin Oncol. 2011;23(3):283–9.
Article
PubMed
PubMed Central
Google Scholar
MacLennan S, et al. Systematic review of oncological outcomes following surgical management of localised renal cancer. Eur Urol. 2012;61:972–93.
Article
PubMed
Google Scholar
Janzen NK, Kim HL, Figlin RA, Belldegrun AS. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol Clin North Am. 2003;30:843–52.
Article
PubMed
Google Scholar
Sun M, Shariat SF, Cheng C, et al. Prognostic factors and predictive models in renal cell carcinoma: a contemporary review. Eur Urol. 2011;60:644–61.
Article
PubMed
Google Scholar
Atzpodien J, Royston P, Wandert T, et al. Metastatic renal carcinoma comprehensive prognostic system. Br J Cancer. 2003;88:348–53.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kim HL, Seligson D, Liu X, et al. Using tumor markers to predict the survival of patients with metastatic renal cell carcinoma. J Urol. 2005;173:1496–501.
Article
CAS
PubMed
Google Scholar
Adashek JJ, Salgia MM, Posadas EM, Figlin RA, Gong J. Role of Biomarkers in Prediction of Response to Therapeutics in Metastatic Renal-Cell Carcinoma. Clin Genitourin Cancer. 2019;17(3):e454–e460. Review.
Article
PubMed
Google Scholar
Majer W, Kluzek K, Bluyssen H, Wesoły J. Potential approaches and recent advances in biomarker discovery in clear-cell renal cell carcinoma. J Cancer. 2015;6(11):1105–13.
Article
CAS
PubMed
PubMed Central
Google Scholar
Reddi KK, Holland JF. Elevated serum ribonuclease in patients with pancreatic cancer. Proc Natl Acad Sci U S A. 1976;73:2308–10.
Article
CAS
PubMed
PubMed Central
Google Scholar
Huggett JF, Novak T, Garson JA, Green C, Morris-Jones SD, Miller RF, et al. Differential susceptibility of PCR reactions to inhibitors: an important and unrecognised phenomenon. BMC Res Notes. 2008;1:70.
Article
PubMed
PubMed Central
CAS
Google Scholar
Connolly ID, et al. The “liquid biopsy”: the role of circulating DNA and RNA in central nervous system tumors. Curr Neurol Neurosci Rep. 2016;16(3):25.
Article
PubMed
CAS
PubMed Central
Google Scholar
Yörüker EE, Holdenrieder S, Gezer U. Blood-based biomarkers for diagnosis, prognosis and treatment of colorectal cancer. Clin Chim Acta. 2016;455:26–32.
Article
PubMed
CAS
Google Scholar
Zane K, et al. Emerging blood-based biomarkers for detection of gastric cancer. World J Gastroenterol. 2015;21(41):11636–53.
Article
CAS
Google Scholar
Nandagopal L, Sonpavde G. Circulating biomarkers in bladder cancer. Bladder Cancer. 2016;2(4):369–79.
Article
PubMed
PubMed Central
Google Scholar
Stroun M, Lyautey J, Lederrey C, et al. About the possible origin and mechanism of circulating DNA apoptosis and active DNA release. Clin Chim Acta. 2001;313(1–2):139–42.
Article
CAS
PubMed
Google Scholar
Pepe MS, Etzioni R, Feng Z, Potter JD, Thompson ML, Thornquist M, et al. Phases of biomarker development for early detection of cancer. J Natl Cancer Inst. 2001;93(14):1054–61.
Article
CAS
PubMed
Google Scholar
Danila DC, Anand A, Schultz N, et al. Analytic and clinical validation of a prostate cancer-enhanced messenger RNA detection assay in whole blood as a prognostic biomarker for survival. Eur Urol. 2014;65(6):1191–7.
Article
CAS
PubMed
Google Scholar
Rodia MT, et al. Systematic large-scale meta-analysis identifies a panel of two mRNAs as blood biomarkers for colorectal cancer detection. Oncotarget. 2016;7(21):30295–306.
Article
PubMed
PubMed Central
Google Scholar
Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol. 1982;6:655–63.
Article
CAS
PubMed
Google Scholar
Sobin LH, Wittekind C. TNM classification of malignant tumours. New York: Wiley-Liss; 2002. p. 193–5.
Google Scholar
Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013;499:43–9.
Article
CAS
Google Scholar
Liu X, Yu X, Zack DJ, Zhu H, Qian J. TIGER: a database for tissue-specific gene expression and regulation. BMC Bioinformatics. 2008;9:271.
Article
PubMed
PubMed Central
CAS
Google Scholar
Boguski MS, Lowe TM, Tolstoshev CM. dbEST--database for “expressed sequence tags”. Nat Genet. 1993;4:332–3.
Article
CAS
PubMed
Google Scholar
Edgar R, Domrachev M, Lash AE. Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002;30:207–10.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lonsdale J, et al. The genotype-tissue expression (GTEx) project. Nat Genet. 2013;45:580–5.
Article
CAS
Google Scholar
Krupp M, Marquardt JU, Sahin U, Galle PR, Castle J, Teufel A. RNA-Seq atlas- a reference database for gene expression profiling in normal tissue by next-generation sequencing. Bioinformatics. 2012;28(8):1184–5.
Article
CAS
PubMed
Google Scholar
Zhao S, et al. Comparison of stranded and non-stranded RNA-seq transcriptome profiling and investigation of gene overlap. BMC Genomics. 2015;16:675.
Article
PubMed
PubMed Central
CAS
Google Scholar
BioMart. http://www.ensembl.org. Accessed 20 Apr 2016.
Jung M, Ramankulov A, Roigas J, Johannsen M, Ringsdorf M, Kristiansen G, et al. In search of suitable reference genes for gene expression studies of human renal cell carcinoma by real-time PCR. BMC Mol Biol. 2007;8:47.
Article
PubMed
PubMed Central
CAS
Google Scholar
Universal Probe Library. www.universalprobelibrary.com. Accessed 5 May 2016.
Uhlen M, et al. A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol Cell Proteomics. 2005;4(12):1920–32.
Article
CAS
PubMed
Google Scholar
Hamosh A, et al. Online Mendelian inheritance in man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res. 2002;30(1):52–5.
Article
CAS
PubMed
PubMed Central
Google Scholar
Meyer HA, Tolle A, Jung M, Fritzsche FR, Haendler B, Kristiansen I, et al. Identification of stanniocalcin 2 as prognostic marker in renal cell carcinoma. Eur Urol. 2009;55:669–78.
Article
CAS
PubMed
Google Scholar
Thibodeau BJ, Fulton M, Fortier LE, Geddes TJ, Pruetz BL, Ahmed S, et al. Characterization of clear cell renal cell carcinoma by gene expression profiling. Urol Oncol. 2016;34(4):168.
Article
PubMed
CAS
Google Scholar
Feng JY, Diao XW, Fan MQ, Wang PX, Xiao Y, Zhong X, et al. Screening of feature genes of the renal cell carcinoma with DNA microarray. Eur Rev Med Pharmacol Sci. 2013;17(22):2994–3001.
PubMed
Google Scholar
Fu L, Minton DR, Zhang T, Nanus DM, Gudas LJ. Genome-wide profiling of track kidneys shows similarity to the human ccRCC transcriptome. Mol Cancer Res. 2015;13(5):870–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Schrödter S, Braun M, Syring I, Klümper N, Deng M, Schmidt D, et al. Identification of the dopamine transporter SLC6A3 as a biomarker for patients with renal cell carcinoma. Mol Cancer. 2016;15:10.
Article
PubMed
PubMed Central
CAS
Google Scholar
Minton DR, Fu L, Mongan NP, Shevchuk MM, Nanus DM, Gudas LJ. Role of NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 4-like 2 in clear cell renal cell carcinoma. Clin Cancer Res. 2016;22(11):2791–801.
Article
CAS
PubMed
PubMed Central
Google Scholar
Klatte T, Kabbinavar F, Zomordian N, Belldegrun AS, Pantuck AJ. Prospective evaluation of carbonic anhydrase IX (CAIX) as a molecular marker in metastatic renal cell carcinoma: interim results. J Urol. 2007;177:164.
Google Scholar
Bruick RK, McKnight SL. A conserved family of prolyl-4-hydroxylases that modify HIF. Science. 2001;294:1337–40.
Article
CAS
PubMed
Google Scholar
Rainen L, Oelmueller U, Jurgensen S, et al. Stabilization of mRNA expression in whole blood samples. Clin Chem. 2002;48:1883–90.
Article
CAS
PubMed
Google Scholar
Ramsköld D, Wang ET, Burge CB, Sandberg R. An abundance of ubiquitously expressed genes revealed by tissue transcriptome sequence data. PLoS Comput Biol. 2009;5(12):e1000598.
Article
PubMed
PubMed Central
CAS
Google Scholar
Magee R, Loher P, Londin E, Rigoutsos I. Threshold-seq: a tool for determining the threshold in short RNA-seq datasets. Bioinformatics. 2017;33(13):2034–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Meyerson M, Enders GH, Wu CL, et al. A family of human cdc2-related protein kinases. EMBO J. 1992;11:2909–17.
Article
CAS
PubMed
PubMed Central
Google Scholar
Matsuda S, Kominato K, Koide-Yoshida S, et al. PCTAIRE kinase 3/cyclin-dependent kinase 18 is activated through association with cyclin a and/or phosphorylation by protein kinase a. J Biol Chem. 2014;289(26):18387–400.
Article
CAS
PubMed
PubMed Central
Google Scholar
Palmer KJ, Konkel JE, Stephens DJ. PCTAIRE protein kinases interact directly with the COPII complex and modulate secretory cargo transport. J Cell Sci. 2005;118:3839–47.
Article
CAS
PubMed
Google Scholar
Matsuda S, Kawamoto K, Miyamoto K, Tsuji A, Yuasa K. PCTK3/CDK18 regulates cell migration and adhesion by negatively modulating FAK activity. Sci Rep. 2017;7:45545.
Article
CAS
PubMed
PubMed Central
Google Scholar
Barone G, Staples CJ, Ganesh A, Patterson KW, Bryne DP, Myers KN, et al. Human CDK18 promotes replication stress signaling and genome stability. Nucleic Acids Res. 2016;44(18):8772–85.
Article
CAS
PubMed
PubMed Central
Google Scholar
Herskovits AZ, Davies P. The regulation of tau phosphorylation by PCTAIRE 3: implications for the pathogenesis of Alzheimer's disease. Neurobiol Dis. 2006;23(2):398–408.
Article
CAS
PubMed
Google Scholar
Chaput D, Kirouac L, Stevens SM Jr, Padmanabhan J. Potential role of PCTAIRE-2, PCTAIRE-3 and P-histone H4 in amyloid precursor protein-dependent Alzheimer pathology. Oncotarget. 2016;7(8):8481–97.
Article
PubMed
PubMed Central
Google Scholar
Naumann U, Huang H, Wolburg H, Wischhusen J, Weit S, Ohgaki H, et al. PCTAIRE3: a putative mediator of growth arrest and death induced by CTS-1, a dominant-positive p53-derived synthetic tumor suppressor, in human malignant glioma cells. Cancer Gene Ther. 2006;5:469–78.
Article
CAS
Google Scholar
Qie S, Diehl JA. Cyclin D1, cancer progression, and opportunities in cancer treatment. J Mol Med (Berl). 2016;94(12):1313–26.
Article
CAS
Google Scholar
Zwijsen RM, Wientjens E, Klompmaker R, van der Sman J, Bernards R, Michalides RJ. CDK-independent activation of estrogen receptor by cyclin D1. Cell. 1997;88(3):405–15.
Article
CAS
PubMed
Google Scholar
Karim S, Al-Maghrabi JA, Farsi HM, Al-Sayyad AJ, Schulten HJ, Buhmeida A, et al. Cyclin D1 as a therapeutic target of renal cell carcinoma- a combined transcriptomics, tissue microarray and molecular docking study from the Kingdom of Saudi Arabia. BMC Cancer. 2016;16(Suppl 2):741.
Article
PubMed
PubMed Central
CAS
Google Scholar
Zhao W, Tian B, Wu C, Peng Y, Wang H, Gu WL, et al. DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma. Pathol Res Pract. 2015;211(4):303–7.
Article
CAS
PubMed
Google Scholar
Kumari S, Panda TK, Pradhan T. Lysyl oxidase: its diversity in health and diseases. Indian J Clin Biochem. 2017;32(2):134–41.
Article
CAS
PubMed
Google Scholar
Zheng W, et al. Low extracellular lysyl oxidase expression is associated with poor prognosis in patients with prostate cancer. Oncol Lett. 2016;12(5):3161–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang TH, Hsia SM, Shieh TM. Lysyl oxidase and the tumor microenvironment. Int J Mol Sci. 2017;8(1):62.
Article
CAS
Google Scholar
Tanaka T, et al. Anthracycline inhibits recruitment of hypoxia-inducible transcription factors and suppresses tumor cell migration and cardiac Angiogenic response in the host. J Biol Chem. 2012;287(42):34866–82.
Article
CAS
PubMed
PubMed Central
Google Scholar
Liep J, Kilic E, Meyer HA, Busch J, Jung K, Rabien A. Cooperative effect of miR-141-3p and miR-145-5p in the regulation of targets in clear cell renal cell carcinoma. PLoS One. 2016;11(6):e0157801.
Article
PubMed
PubMed Central
CAS
Google Scholar
Di Stefano V, Torsello B, Bianchi C, Cifola I, Mangano E, Bovo G, et al. Major action of endogenous Lysyl oxidase in clear cell renal cell carcinoma progression and collagen stiffness revealed by primary cell cultures. Am J Pathol. 2016;186(9):2473–85.
Article
PubMed
CAS
Google Scholar